World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 21 July 2016
Main ID:  NCT02736019
Date of registration: 08/04/2016
Prospective Registration: Yes
Primary sponsor: Cairo University
Public title: Tramadol Versus Celecoxib for Reducing Pain During Office Hysteroscopy in Post Menopausal Women
Scientific title: Tramadol Versus Celecoxib for Reducing Pain During Office Hysteroscopy in Post Menopausal Women: A Double Blind Randomized Controlled Trial
Date of first enrolment: June 2016
Target sample size: 210
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT02736019
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention  
Phase:  Phase 3
Countries of recruitment
Egypt
Contacts
Name:     AbdelGany M Hassan, MRCOG, MD
Address: 
Telephone: +201017801604
Email: abdelgany2@gmail.com
Affiliation: 
Name:     AbdelGany MA Hassan, MRCOG, MD
Address: 
Telephone: 00217801604
Email: abdelgany2@gmail.com
Affiliation: 
Name:     AbdelGany M Hassan
Address: 
Telephone:
Email:
Affiliation:  Cairo University
Key inclusion & exclusion criteria

Inclusion Criteria:

- Post menopausal women.

- vaginal bleeding.

- Endometrial thickness >4mm.

Exclusion Criteria:

- Medical disorders like uncontrolled diabetes or hypertension, cardiac, renal , liver
disease.

- Gastritis or peptic ulcer.

- Allergy to Tramadol or Celecoxib.



Age minimum: 50 Years
Age maximum: 70 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Hysteroscopy
Intervention(s)
Drug: Placebo 2
Drug: Placebo 1
Drug: Celecoxib
Drug: Tramadol
Primary Outcome(s)
Patient's perception of pain during the procedure [Time Frame: 2 minutes after starting the procedure]
Secondary Outcome(s)
Pain after the procedure [Time Frame: 30 minutes after completing the procedure]
Secondary ID(s)
Hyst 7
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history